ARTICLE | Company News
Helsinn, Stendhal deal
February 23, 2015 8:00 AM UTC
Helsinn granted Stendhal exclusive rights to commercialize netupitant/palonosetron ( NEPA) in Colombia, Ecuador, Mexico, Peru, Venezuela and undisclosed Central American countries. The product is a f...